SBRT vs 20-fraction RT for any-risk prostate cancer: ePRO-measured acute toxicity in a randomised trial (OPTIMAL)


Date
Sep 8, 2021 6:30 PM — Sep 10, 2022 4:30 PM
Location
Hobart
Thilo Schuler MD MHInf
Thilo Schuler MD MHInf
Radiation Oncology Doctor

I am a practicing medical doctor with 10 years’ experience in Radiation Oncology and long track record of successful implementation of digital health projects to drive innovation in clinical research and practice. My passion to improve cancer care with digital health has led me to pursue a PhD. It focuses on the translation of patient-generated health data in routine oncology care to optimally support cancer patients and their families.